文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

产前流感疫苗接种与儿童期流感感染的纵向人群队列研究

Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood.
PubMed 文献 · Vaccine · 2022-01-07

该研究利用概率链接的行政健康记录建立母婴队列,评估母亲孕期接种流感疫苗与儿童流感及急性呼吸道感染风险的关系。结果显示,母亲接种疫苗的婴儿在6个月内实验室确诊流感、流感相关住院和急性呼吸道感染住院风险均降低;但孕早期接种后6个月至2岁儿童实验室确诊流感风险升高,6个月后其他结局无差异。结论认为母亲流感疫苗接种对预防婴儿前6个月流感有效,对2岁后呼吸道感染无影响。

要点

  • 母亲接种疫苗的婴儿6个月内实验室确诊流感风险降低(aHR 0.33)。
  • 母亲接种疫苗的婴儿6个月内流感相关住院风险降低(aHR 0.39)。
  • 孕早期接种后6个月至2岁儿童实验室确诊流感风险升高(aHR 2.28)。

核心结论

  • 母亲流感疫苗接种对预防婴儿前6个月流感有效,对2岁后呼吸道感染无影响。

研究设计与样本

  • 采用概率链接的行政健康记录建立母婴队列,评估母亲流感疫苗接种与儿童流感及急性呼吸道感染风险的关系。
  • 结局为实验室确诊流感(LCI)和流感或急性呼吸道感染(ARI)住院;调整风险比(aHR)考虑了儿童原住民身份并按治疗逆概率加权。
  • 共有14,396名(11.5%)儿童的母亲接种过疫苗。

主要发现

  • 母亲接种疫苗的6个月内婴儿较母亲未接种婴儿,实验室确诊流感风险降低(aHR 0.33;95% CI 0.13, 0.85)。
  • 母亲接种疫苗的6个月内婴儿较母亲未接种婴儿,流感相关住院风险降低(aHR 0.39;95% CI 0.16, 0.94)。
  • 母亲接种疫苗的6个月内婴儿较母亲未接种婴儿,急性呼吸道感染住院风险降低(aHR 0.85;95% CI 0.77, 0.94)。
  • 孕早期接种后6个月至2岁儿童实验室确诊流感风险升高(aHR 2.28;95% CI 1.41, 3.69)。
  • 6个月以上儿童中,实验室确诊流感、流感相关住院或急性呼吸道感染住院风险无其他差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza vaccination is recommended to protect mothers and their infants from influenza infection. Few studies have evaluated the health impacts of in utero exposure to influenza vaccine among children more than six months of age. METHODS: We used probabilistically linked administrative health records to establish a mother-child cohort to evaluate the risk of influenza and acute respiratory infections associated with maternal influenza vaccination. Outcomes were laboratory-confirmed influenza (LCI) and hospitalization for influenza or acute respiratory infection (ARI). Adjusted hazard ratios (aHRs) accounted for child's Aboriginal status and were weighted by the inverse-probability of treatment. RESULTS: 14,396 (11.5%) children were born to vaccinated mothers. Maternally vaccinated infants aged < 6 months had lower risk of LCI (aHR: 0.33; 95% CI: 0.13, 0.85), influenza-associated hospitalization (aHR: 0.39; 95% CI: 0.16, 0.94) and ARI-associated hospitalization (aHR: 0.85; 95% CI: 0.77, 0.94) compared to maternally unvaccinated infants. With the exception of an increased risk of LCI among children aged 6 months to < 2 years old following first trimester vaccination (aHR: 2.28; 95% CI: 1.41, 3.69), there were no other differences in the risk of LCI, influenza-associated hospitalization or ARI-associated hospitalization among children aged > 6 months. CONCLUSION: Study results show that maternal influenza vaccination is effective in preventing influenza in the first six months and had no impact on respiratory infections after two years of age.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Foo D, Sarna M, Pereira G, et al. Longitudinal, population-based cohort study of prenatal influenza vaccination and influenza infection in childhood. Vaccine. 2022. PMID: 35000794. doi:10.1016/j.vaccine.2021.11.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。